Related Experiment Video
Updated: Jul 27, 2026
08:48
Dynamic Monitoring of Seroconversion using a Multianalyte Immunobead Assay for Covid-19
Published on: February 16, 2022
3.2K
COVID-19 Clinical Diagnostics and Testing Technology
Cindy H Chau1, Jonathan D Strope1, William D Figg1
1Genitourinary Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA.
Pharmacotherapy
|July 10, 2020
Summary
Rapid advancements in diagnostic technologies are crucial for controlling the COVID-19 pandemic. This review covers molecular and serological testing for SARS-CoV-2, emphasizing the need for improved detection methods.
Area of Science:
- Virology
- Medical Diagnostics
- Biotechnology
Background:
- The COVID-19 pandemic necessitates urgent development and scaling of effective disease detection methods.
- Accurate and accessible testing for SARS-CoV-2 is vital for global health security.
Purpose of the Study:
- To review current and emerging technologies for detecting SARS-CoV-2.
- To analyze the advantages and limitations of molecular and serological diagnostic approaches.
- To highlight the importance of improving testing capacity and accessibility.
Main Methods:
- Review of existing literature on COVID-19 diagnostic technologies.
- Analysis of molecular diagnostic techniques, including nucleic acid amplification tests (NAATs).
- Evaluation of serological testing methods for antibody detection and their validation.
Main Results:
- Nucleic acid amplification technology is the current gold standard for SARS-CoV-2 detection.
- Alternative molecular detection methods are under development for rapid diagnostics.
- Serological test validation is critical due to incomplete understanding of antibody responses.
Conclusions:
- Continued innovation in diagnostic technology is essential for pandemic control.
- Improvements in clinical diagnostics and testing accessibility are paramount.
- Widespread, rapid testing is key to managing the COVID-19 pandemic effectively.
Related Concept Videos
01:25Rapid Identification of Pathogens
MALDI-TOF MS has transformed clinical microbiology by offering a rapid and reliable method for pathogen identification. The traditional approach to microbial identification typically involves time-consuming culture techniques and biochemical tests, which can delay the initiation of appropriate antimicrobial therapy. MALDI-TOF MS avoids these delays by using characteristic ribosomal protein mass patterns of microbial cells, enabling accurate species-level identification within minutes.Principle...
01:24Automated Microbial Diagnostics
Automated diagnostic analyzers have transformed clinical microbiology by providing rapid and reliable methods for pathogen identification and antibiotic susceptibility testing. Among these systems, the Vitek 2 is widely used because it automates the traditionally labor-intensive processes of microbial identification (ID) and antibiotic susceptibility testing (AST), delivering standardized and timely results that are essential for effective patient care.Microbial Identification with ID CardsThe...